We'd like to know if something's changed. Has the FDA increased inspections, have they increased in rigor, are new testing methods being used that are more sensitive in picking up problems?

We're concerned there's a trend toward critical drugs being made by just one company. When companies merge, some products are discontinued for a variety of reasons.